We provide consulting services to life sciences companies globally. Past projects include everything from desk research on new disease areas to global commercial assessments for new products. We have developed hundreds of forecast models and decision support tools. In addition, our SLRs, meta analyses and health economic models have been used by clients to support pricing negotiations globally.


Our team develops discussion guides, runs telephone interviews, and moderates focus groups. Our tech group programmes online surveys, recruits respondents globally and helps develop outputs.


Please email us ( for a meeting if you are looking to commercialise a new product, change existing strategy, set pricing strategy or value an asset for in-licensing / out-licensing / partnering.

We can guarantee you high quality work.


We can help you understand the potential of specific therapeutic areas, country markets, soon-to-be launched products and early stage molecules, including intellectual property. Our offerings are designed to maximize returns from your R&D, business development, licensing and marketing efforts.

We conduct primary market research, secondary research and data analysis to help develop strategy at the product and business level. We set up custom models for quantitative assessment of strategies, scenario analyses and development of strategic options. The information and analysis that we deliver along with our decision tools facilitate structured thinking and decision making.

We run workshops and participate in on-site meetings as needed to provide support to clients during projects.

We are unique in having the processes and resources in place to provide rapid turnarounds with global projects. With many projects, we can deliver outputs in under 4 weeks from commissioning. 


Our services are designed to help with Market Access, Business Development & Licensing, Business Analysis, Strategic Planning, Strategic Marketing and Pricing & Reimbursement.

We have the skills and resources to conduct market, product and service evaluations globally – USA, EU, Japan, China – including emerging markets. We have extensive experience in conducting global opportunity assessments for medicines at all stages in their life cycle.

We have been in this space for 18 years now and have conducted projects to support decisions around (a) funding for early stage companies, (b) advancing an asset across phases of clinical trials, (c) drug licensing opportunities, (d) valuation of revenue streams for monetization (e) pricing new products, (f) market scoping and (g) developing a viable target product profile. We have developed forecasts for hundreds of new products, including valuations for many. We also develop health economic models including evidence synthesis to support pricing and reimbursement. 

If you are a smaller consulting firm or a freelance consultant and require support with a consulting project, we can work with you at any stage of the project or for completing any module within the project. This may include help with secondary research, primary research globally, Excel model development for forecasting, Markov or decision tree model development for cost effectiveness analysis or just about any work associated with the project. Please feel free to contact us with your requirement.

Focus areas
Market opportunity assessment

TPP evaluation

Market sizing


Primary market research

Secondary research

Online surveys

Conjoint & choice studies

Payer research

Systematic review for assumptions

Microsimulation models

Markov models

Disease area strategy

Portfolio strategy

Product strategy

Planning workshops

Valuation of assets

In licensing / out licensing

Royalty stream valuation

Equity / debt valuation